… Today, The Michael J. Fox Foundation joined 87 patient … appearing in the current issue of USA Today , highlights how research can improve health outcomes and help reduce medical costs. Congress is currently …

… At The Michael J. Fox Foundation (MJFF), we're on a mission to cure Parkinson's disease (PD). As 2017 winds down, we reflect, with tremendous hope and anticipation, on how much closer we are to fulfilling this goal and improving … than 54,000 times on various policy issues affecting the PD community . The drug development pipeline is abuzz with …

… Veterans and Parkinson’s: Three Things to Know The Michael J. Fox Foundation works to support all individuals living with Parkinson’s, including … Island Clipperton Island Cocos (Keeling) Islands Colombia Comoros Congo - Brazzaville Congo - Kinshasa Cook Islands …

… Study Rationale: The protein alpha-synuclein is vital to normal brain function. In Parkinson's disease, … Sampling Study (S4) . Th e study aims to determine if and how alpha-synuclein can be used to diagnose Parkinson's, … Design: This study will determine the clinical utility and compare the performance of the  alpha -synuclein RT-QuIC …

… Attention Bostonians!  Please join the Team Fox Young Professionals of … finding a cure for Parkinson's disease, it's a win-win. Come support a great cause, help the Boston YPs spread … THE GROUP WITH THE BEST ENSEMBLE WILL BE AWARDED A PRIZE! GET CREATIVE WITH IT! About The Team Fox Boston Young …

… We have previously found that in autopsied patients with Parkinson’s disease (PD) the hallmark … submandibular gland tissue that was identifiable, 9 (75%) showed LTS. This is close to the expected percentage of PD … imaging, and other biomarker studies. Anticipated Outcome:           We expect to determine whether submandibular …